GLPwatch
Trials (2167)
Page 35 of 37.
- Separate and Combined Extrapancreatic Effects of the Incretin Hormones
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
- A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
- The Effect of Exenatide on Fasting Bile Acids
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
- Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
- Effects of Obesity Treatments on Food Preferences and Metabolism
- Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
- A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
- A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe
- Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
- GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
- Tirzepatide in Idiopathic Intracranial Hypertension Trial
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
- Tirzepatide Weight Loss for MRD+ Early Breast Cancer
- Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
- Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
- Multi-Site Trial of Tirzepatide for Smoking Cessation
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
- 52 Week Trial of Liraglutide in Type 1 Diabetes
- A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
- Observational Study of ASCVD Risks of Type 2 Diabetes in East China
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Weight Loss With Exenatide Treatment
- A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
- Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
- A Study of CS060380 Tablets in Patients With MASH and Obesity
- A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
- LIraglutide and Beta-cell RepAir (LIBRA) Study
- A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
- GLP-1 Medicines and Mental Health Changes
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
- A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
- Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
- A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
- AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
- LIROH - Liraglutide for Obesity in HIV
- Semaglutide and Vascular Regeneration
- The Effect of Liraglutide on Pancreatic Hormones and Its Size
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables